Dariohealth reports fourth quarter and full year 2021 results and operational highlights

New york, march 22, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio), a leader in the global digital therapeutics (dtx) market, today reported financial results for the fourth quarter and full year 2021 and provided a corporate and commercial update. "the last year completely transformed dario's company profile as our business-to-business (b2b) business grew significantly, both in terms of signed and launched, revenue-generating accounts and the overall growth of opportunity attributed to our integrated, multi-condition approach.
DRIO Ratings Summary
DRIO Quant Ranking